Navigation

Lung cancer (non-small-cell) - erlotinib

Erlotinib for the treatment of non-small cell lung cancer

Status: History
Expected date of issue: November 2008
Process: STA
Topic area:
  • Cancer
  • Respiratory
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: Prashanth Kandaswarmy
Communications manager: Alice Law
Project manager: Chris Feinmann
Assessment Group / Evidence Review Group: Liverpool Reviews and Implementation Group (LRiG), University of Liverpool
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: 23 May 2006
1st appraisal committee meeting: 11 October 2006
2nd appraisal committee meeting 11 January 2007
3rd appraisal committee meeting: 16 January 2008
4th appraisal committee meeting: 11 June 2008
5th appraisal committee meeting: 13 August 2008
Top


 

Consultees and commentators

Consultees Commentators (no right of appeal)

Manufacturers / Sponsors

  • Roche Products Ltd

 

Patient / Carer Groups

  • CancerBACKUP
  • Roy Castle Lung Cancer Foundation
  • Tenovus Cancer Information Centre

 

Professional Groups

  • British Thoracic Society
  • Cancer Networks Pharmacists forum
  • Cancer Research UK
  • Royal College of General Practitioners
  • Royal College of Nursing
  • Royal College of Pathologists
  • Royal College of Physicians, Medical Oncology Joint Special Committee

 

Others

  • Department of Health
  • Welsh Assembly Government

 

General

  • British National Formulary
  • NHS Quality Improvement Scotland
  • National Public Health Service for Wales

 

Comparator Manufacturers

  • Eli Lilly and Company Ltd
  • Sanofi-Aventis

 

Evidence Review Groups

  • Liverpool Reviews and Implementation Group, University of Liverpool
  • National Coordinating Centre for Health Technology Assessment

 

Associated Guideline Groups

  • National Collaborating Centre for Cancer

 

Associated Public Health Groups

  • None

 

Research Groups

  • British Thoracic Oncology Group
  • Institute of Cancer Research
  • MRC CTU - Lung Cancer and Mesothelioma Group

Top


 

Project history

Date Update
11 April 2006 Consultee and commentators added
3 August 2006 Schedule updated
23 November 2006 Stakeholders updated
6 March 2007 Schedule updated
16 June 2007 Appeal held
12 November 2007 Schedule updated
29 November 2007 Project team updated
Top


 

Key documents

This page was last updated: 30 March 2010

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.